This study is a clinical trial designed to determine the effect of valerian, lemon balm oral capsules and their combined consumption on the symptoms of menopause in women aged 45-60. 120 healthy postmenopausal volunteers referred to Imam Khomeini clinic and Imam Hussein clinic (30 persons in each group) eligible of entry criteria (cessation of menstruation for at least 12 months due to menopause, no history of allergy to valerian, lemon balm, and their combination, etc.) were enrolled into the study after completing informed consent. Exclusion criteria were including any adverse effects during treatment including allergies to treatment capsules and no consumption of them to a maximum period of seven days or more per month of consumption, drug use, occurrence of any individual or family crises, and changes in diet and lifestyle such as changes to vegetarianism, health or addiction problems throughout research process. The subjects include three groups: treated with valerian, lemon balm, their combined form and the control group. The treatment group received 530 mg capsules of valerian (plant roots), or 250 mg Lemon Balm (plant leaves), or a combination of 160 mg valerian and 80 mg lemon balm, or 300 mg starch (controls) (capsules of the same form twice a day for eight weeks). The instruments of study consisted of demographic questionnaire, treatment registration forms and instrument of menopause evaluation criteria (physical, psychological and genitourinary dimensions) recorded and compared before treatment and then four and eight weeks after treatment.